Oireachtas Joint and Select Committees

Wednesday, 8 November 2017

Joint Oireachtas Committee on Health

Evaluating Orphan Drugs: Discussion (Resumed)

9:00 am

Photo of Michael HartyMichael Harty (Clare, Independent) | Oireachtas source

The Deputy may ask a supplementary question later. I must allow other members to contribute. I have another question. What is the manner of engagement with patient groups because such groups feel they are not being engaged with in a meaningful manner? What about representative organisations and specialists in the field where the drug applies, who feel they are not being engaged in a meaningful manner? What is the manner of engagement?

Comments

No comments

Log in or join to post a public comment.